Corbus Pharmaceuticals

On the turnaround trail, tiny Corbus pays $7.5M for rival to Seagen's oncology ADC Padcev
On the turnaround trail, tiny Corbus pays $7.5M for rival to Seagen's oncology ADC Padcev
Fierce Biotech
Corbus Pharmaceuticals
Seagen
Padcev
CRB-701
oncology
Flag link:
ESMO 2021 movers – a handful of biotech winners emerge
ESMO 2021 movers – a handful of biotech winners emerge
EP Vantage
ESMO
Corbus Pharmaceuticals
Leap Therapeutics
Surface Oncology
AstraZeneca
Innate Pharma
Immunocore
Daiichi Sankyo
Verastem
Spectrum Pharrmaceuticals
Mirati Therapeutics
Flag link:
3 Biotech Stocks With Big Catalysts in June
3 Biotech Stocks With Big Catalysts in June
Motley Fool
Corbus Pharmaceuticals
lenabasum
clinical trials
Gemini Therapeutics
age-related macular degeneration
Intellia Therapeutics
hATTR-pn
Flag link:
Corbus craters on ‘surprising’ late-stage lenabasum flop
Corbus craters on ‘surprising’ late-stage lenabasum flop
Fierce Biotech
Corbus Pharmaceuticals
cutaneous systemic sclerosis
clinical trials
lenabasum
Flag link:
Gilead/Galapagos, Intercept and Corbus trials could be hit by coronavirus spread: analyst
Gilead/Galapagos, Intercept and Corbus trials could be hit by coronavirus spread: analyst
Fierce Biotech
clinical trials
Gilead Sciences
Galapagos
Corbus Pharmaceuticals
Intercept Pharmaceuticals
coronaviruses
COVID-19
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
ADA
Merck
Keytruda
NGM Biopharmaceuticals
NGM313/MK-3655
Corbus Pharmaceuticals
Nektar
Galapagos
Kezar Life Sciences
Kura Oncology
Bluebird Bio
BeiGene
Global Blood Therapeutics
Blueprint Medicines
Regeneron
Arqule
Sunesis
Sutro BioPharma
Incyte
Geron
Forty Seven
Flag link:
3 Biotech Stocks That Soared This Week
3 Biotech Stocks That Soared This Week
Motley Fool
Viking Therapeutics
Acadia Pharmaceuticals
Corbus Pharmaceuticals
Flag link:
Why Corbus Pharmaceuticals Holdings Inc. Tumbled Today
Why Corbus Pharmaceuticals Holdings Inc. Tumbled Today
Motley Fool
Corbus Pharmaceuticals
cannabindoids
drug development
Flag link:
Corbus drug aces second mid-stage trial, this time in cystic fibrosis
Corbus drug aces second mid-stage trial, this time in cystic fibrosis
Bizjournals.com
Corbus Pharmaceuticals
clinical trials
cystic fibrosis
anabasum
Flag link:
Inside the small Norwood biotech that's making investors swoon
Inside the small Norwood biotech that's making investors swoon
Bizjournals.com
Corbus Pharmaceuticals
autoimmune disease
Flag link:
Biotech's Top 3 Stock Losers, and Winners, in 2016
Biotech's Top 3 Stock Losers, and Winners, in 2016
Forbes
biotech
Concordia
Ophthotech
Cempra
Corbus Pharmaceuticals
CoLucid
AveXis
Flag link:
These 15 Biotech Companies Could Be Takeover Targets
These 15 Biotech Companies Could Be Takeover Targets
Barron's
biotech
M&A
Alder Biopharmaceuticals
Biomarin
Coherus Biosciences
Intercept Pharma
Ultragenyx
Seattle Genetics
Adamas Pharmaceuticals
Alexion
Clovis Oncology
Corbus Pharmaceuticals
Incyte
Prothena
Puma Biotechnology
Tesaro
Versartis
Flag link:
4 Ignored Biotech Stocks for 2016
4 Ignored Biotech Stocks for 2016
24/7 Wall St
ANI Pharmaceuticals
Corbus Pharmaceuticals
Geron
Ardelyx
Flag link:
Execs behind Imbruvica raise $75M for a new cancer project
Execs behind Imbruvica raise $75M for a new cancer project
Fierce Biotech
Imbruvica
Corbus Pharmaceuticals
cancer
Flag link:
What Lit a Fire Under These 3 Pharma Stocks
What Lit a Fire Under These 3 Pharma Stocks
24/7 Wall St
Aveo Pharmaceuticals
Omeros
Corbus Pharmaceuticals
Flag link:
Corbus' shares soar on FDA news that could speed up drug approval
Corbus' shares soar on FDA news that could speed up drug approval
Bizjournals.com
Resunab
Corbus Pharmaceuticals
FDA
fast track
Flag link:
In the shadow of Vertex, small cystic fibrosis-focused biotechs thrive
In the shadow of Vertex, small cystic fibrosis-focused biotechs thrive
Bizjournals.com
Vertex Pharmaceuticals
cystic fibrosis
Pulmatrix
Corbus Pharmaceuticals
Flag link: